ERBB2 and breast cancer: As a highly heterogeneous cancer, BC can be divided into various distinct subtypes according to gene expression profiling, such as luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-positive and basal-like (triple-negative) BC (1).